EGFR and breast carcinoma: In the same type of tumor cells (ESCC, NSCLC, breast cancer), the EGFR‐overexpressing cancer cells were more sensitive to LR004‐VC‐MMAE than the EGFR low‐expressing cells, in terms of the IC50 values.